European Companies Search Engine
Decibel Therapeutics Inc., Boston, United States
Watch
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
Dossier
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Decibel Therapeutics Inc.
Identification
Stockp
DBTX
Address
Corporate purpose
2834
Pharmaceutical Preparations
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in … Show more
History
Network
Loading network
Annual report
Publications
29 Sept 2023
Year 2022
in
Epobase
Year 2020
in
Epobase
There are no publications matching your search.
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "Decibel Therapeutics Inc., Boston, United States"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
